Cargando…
Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction]
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142340/ https://www.ncbi.nlm.nih.gov/pubmed/35637839 http://dx.doi.org/10.2147/IJN.S375352 |
| _version_ | 1784715553462550528 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9142340 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91423402022-05-29 Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction] Int J Nanomedicine Retraction Dove 2022-05-23 /pmc/articles/PMC9142340/ /pubmed/35637839 http://dx.doi.org/10.2147/IJN.S375352 Text en © 2022 Dove Medical Press. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Retraction Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction] |
| title | Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction] |
| title_full | Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction] |
| title_fullStr | Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction] |
| title_full_unstemmed | Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction] |
| title_short | Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction] |
| title_sort | tumour-targeted and redox-responsive mesoporous silica nanoparticles for controlled release of doxorubicin and an sirna against metastatic breast cancer [retraction] |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142340/ https://www.ncbi.nlm.nih.gov/pubmed/35637839 http://dx.doi.org/10.2147/IJN.S375352 |